E. Chéreau

Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial

Roman Rouzier, Sébastien Gouy, Frédèric Selle et al. · European Journal of Cancer · 2016 · 107 citations · Full text

Maximal Cytoreduction in Patients With FIGO Stage IIIC to Stage IV Ovarian, Fallopian, and Peritoneal Cancer in Day-to-Day Practice

Mathieu Luyckx, Éric Leblanc, Thomas Filleron et al. · International Journal of Gynecological Cancer · 2012 · 106 citations

Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer

E. Chéreau, Marcos Ballester, Frédèric Selle et al. · American Journal of Obstetrics and Gynecology · 2010 · 92 citations

Prognostic Evaluation, Cancer Detection, Advanced Ovarian Cancer +9

Urinary dysfunction after colorectal resection for endometriosis: results of a prospective randomized trial comparing laparoscopy to open surgery

Marcos Ballester, E. Chéreau, Gil Dubernard et al. · American Journal of Obstetrics and Gynecology · 2011 · 76 citations

Laparoscopy, Urology, Pelvic Prolapse +5

CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy

A Pélissier, Claire Bonneau, E. Chéreau et al. · Gynecologic Oncology · 2014 · 66 citations

Neoadjuvant Chemotherapy, Optimal Cytoreduction, Medicine +8